STEVE ASELAGE - 07 Oct 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
07 Oct 2021
Net transactions value
-$600,960
Form type
4
Filing time
08 Oct 2021, 16:18:33 UTC
Previous filing
02 Sep 2021
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Options Exercise $973,800 +60,000 +32% $16.23 249,794 07 Oct 2021 Direct
transaction TVTX Common Stock Sale $734,440 -28,000 -11% $26.23 221,794 07 Oct 2021 Direct F1
transaction TVTX Common Stock Sale $840,320 -32,000 -14% $26.26 189,794 07 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -60,000 -43% $0.000000 80,000 07 Oct 2021 Common Stock 60,000 $16.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 The stock option is fully vested and exercisable.